Embed Size (px)
Citation preview
IN THE PREMIER LEAGUEGlobally India ranks among top 3 genericformulation exporters in Volume terms
LEADING THE WORLDIndia is among the top six producers
of pharmaceuticals in the world.
ADMINISTERING HEALTHIndia ranks fourth in terms of total pharmamarket share in the Asia Pacific
EXCELLENCE BEYOND COMPAREGlobally more than 90 per cent of formulationsapprovals for Anti-retroviral (ARVs), Anti-tubercular& Anti-malarial (WHO pre-qualified) have beengranted to India.
FILES OF HEALTHIndia accounts for 30.3 per cent (2,911) of 9619
Drug Master Files (DMFs) filed with USA, which
is the highest outside of USA
A GIANT MARKET SHAREIndia's pharmaceutical industry accounts forabout 1.4 per cent of the global pharmaceuticalindustry in value terms
HOME TO EXCELLENCE6 out of top 20 generic companies are from India.
CATALYSING GROWTHIndia's pharma exports stood at US$ 15.3 billion
in 2014-15
TRUSTED QUALITYFinished generics supplied from India account for
3.3 per cent of the global generics market by value.
WORLD RENOWNED QUALITYIndia has about 1400 WHO GMP approvedmanufacturing units
A PHARMA HUBCurrently there are 10,500 manufacturing units and
over 3,000 pharma companies in India, growing at
an exceptional rate.
GROWING CAPABILITIESPharmaceutical exports have grown at a CAGR
of 21% per cent over the last decade
MANUFACTURING EXCELLENCEIndia has been accredited with approximately
1187 CEPs, more than 950 TGA and 584 sites
approved by USFDA
INOCULATING THE WORLDIndian vaccines are exported to 150 countries
THE CHAMPION BOOSTERIndia produces 40-70 per cent of the WHO demand
for DPT & BCG and 90 per cent of measles vaccine.
A HELPING HANDApproximately 70 per cent of the patients indeveloping countries receive Indian medicinesthrough NGOs like The Clinton Foundation, Bill& Melinda Gates Foundation, Doctors WithoutBorders, the UNCTAD etc
AFFORDABLE QUALITYManufacturing costs in India are approximately35-40 per cent of those in the US due to lowinstallation and manufacturing costs
THE HEALING TOUCHHealthcare expenditure by the Government
of India is expected to touch US$ 91 billion
by 2015
DEDICATED TO EXCELLENCE19 dedicated pharmaceutical SEZs in India
are at various stages of development.
CREDIBLE AFFORDABLE SUSTAINABLE
(Set up by Ministry of Commerce & Industry, Govt. of India)www.pharmexcil.com
India Brand Equity Foundation (IBEF) is a Trustestablished by the Department of Commerce,Ministry of Commerce and Industry,Government of India. IBEF’s primary objective isto promote and create international awarenessof the label in markets overseasMade in India
and to facilitate dissemination of knowledgeof Indian products and services. Towards thisobjective, IBEF works closely with stakeholdersacross government and industry.
India Brand Equity FoundationApparel House5th Floor 519-22, Sector 44, Gurgaon - 122003Tel: +91 124 4499600 Fax: +91 124 4499615Email: [email protected] us at www.ibef.orgwww.brandindiapharma.in
Head Office
101, Aditya Trade CentreAmeerpet, Hyderabad - 500038, India
Tel: +91 40 23735462/5466Fax: +91 40 23735464Email: [email protected]
(Set up by Ministry of Commerce & Industry, Govt. of India)www.pharmexcil.com
